(Total Views: 69)
Posted On: 06/28/2023 8:35:45 AM
Post# of 89054
$CLRB News Article - Cellectar Biosciences Highlights Promising Interim Data from Its Ongoing Study of Iopofosine I 131 in Multiple Myeloma in an Oral Presentation at the SNMMI Annual Meeting https://marketwirenews.com/news-releases/cell...19027.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
